Crystallization
The Porton Pharma Crystallization Technology Platform is led by a team of scientists with extensive experience at the world's top pharmaceutical enterprises and equipped with industry-leading instruments. Our business covers comprehensive fields including solid-state research, crystallization process development, preformulation study, particle engineering, and coprocessing. To date, the platform has solved crystallization challenges for over 800 small-molecule pharmaceutical ingredients and intermediates. We are committed to providing full-process customized solutions for crystal form and crystallization process challenges in the pharmaceutical CMC stage.
An Integrated Bridge Between DS and DP, Led by the Porton Crystallization Technology Platform
The World's Most Advanced and comprehensive Crystallization R&D Equipment
Efficient Coordination Between CN and US R&D Center
Case Studies
Marketing Collateral
How to Perform the Development of Conventional/Novel Pre-formulations？
What are the main contents of Crystallization Process Development?
The Power of SC-XRD & Polymorph Quantitation in Drug Development
Why conduct salts/cocrystals screening?How to Conduct Salts/Cocrystals Studies?
How to conduct Polymorphic Screening Efficiently?
What is solid-state study during drug development and why is it necessary?
